Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Launched by MARIANNE ANDERSEN · Feb 2, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Testosterone Treatment for Transgender Men and Non-binary Persons**
This clinical trial, called the BODY IDENTITY CLINIC, aims to learn more about the effects of testosterone treatment on transgender men and non-binary individuals. Researchers will look at important areas such as heart health, muscle strength, levels of aggression, and overall quality of life before and during the treatment. The goal is to better understand how testosterone impacts these individuals.
If you identify as a transgender man or non-binary and are between the ages of 65 and 74, you may be eligible to participate in this study. There are no specific exclusion criteria, so if you meet the age and gender requirements, you could be considered. Participants can expect to undergo assessments related to their cardiovascular and respiratory health, as well as evaluations of their muscle strength and quality of life. This research is valuable as it helps to fill gaps in knowledge about the health of transgender individuals undergoing hormone therapy. If you are interested in contributing to this important work, consider reaching out to learn more about the trial and how to participate.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Transgender men
- Exclusion Criteria:
- • none
About Marianne Andersen
Marianne Andersen is a dedicated clinical trial sponsor with a strong commitment to advancing medical research through innovative study designs and rigorous methodologies. With extensive experience in managing clinical trials across various therapeutic areas, Andersen focuses on enhancing patient outcomes and ensuring safety and efficacy in new treatments. Her collaborative approach fosters partnerships with healthcare professionals and research institutions, driving forward the development of groundbreaking therapies that address unmet medical needs. Through meticulous oversight and a patient-centered ethos, Marianne Andersen is poised to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Trial Officials
Marianne Andersen
Principal Investigator
Odense University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials